Page last updated: 2024-09-03

omega-n-methylarginine and tcv 309

omega-n-methylarginine has been researched along with tcv 309 in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010)
(omega-n-methylarginine)
Studies
(tcv 309)
Trials
(tcv 309)
Recent Studies (post-2010) (tcv 309)
4,4113443366820

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, F; Imai, T; Morita, T; Saito, S; Shiga, T; Yoshikawa, D1

Other Studies

1 other study(ies) available for omega-n-methylarginine and tcv 309

ArticleYear
Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat.
    European journal of pharmacology, 1998, Jan-26, Volume: 342, Issue:2-3

    Topics: Animals; Blood Pressure; Blood Vessels; Decerebrate State; Endotoxins; Enzyme Inhibitors; In Vitro Techniques; Isoquinolines; Male; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetrahydroisoquinolines; Vasoconstrictor Agents

1998